I have been buying some small lots last few days. Honestly, I am still waiting to hear something on the Malaysia signing. To me that is still a pretty big deal and so is the China deal. Either one of those signings is a big confidence boost as well for the company and I would think for any investor.

With the S-1s files, that's a huge burden off of Generex / NGIO and goes a long way to their goal of getting on NASDAQ, but the Peptide results, the signings would put them over the top.